RASSF1 and Wilms tumor: Recently, we reported frequent CASP8 (43%) and RASSF1A (56%) promoter methylation in Wilms' tumours and the present study has demonstrated that SLIT2 methylation represents a further frequent epigenetic change in Wilms' tumours.